An evidence-based network approach to recommending targeted cancer therapies
Jayaram KancherlaiD, Shruti RaoiD, Krithika BhuvaneshwariD, Rebecca Baab RigginsiD, Robert A. BeckmaniD, Subha MadhavaniD, Héctor Corrada BravoiD, Simina Maria BocaiD
Abstract
In this work, we introduce CDGnet, an evidence-based network approach for recommending targeted cancer therapies, available as a user-friendly informatics tool. Our approach can be used to expand the range of options of targeted therapies for cancer patients who undergo molecular profiling. It considers biological pathway information specifically by looking at downstream targets of oncogenes and is personalized for individual patients via the user-inputted molecular alterations and cancer type. CDGnet integrates disparate sources of knowledge and provides results in a number of easily-accessible and usable forms, while separating targeted cancer therapies into categories in an evidence-based manner.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 8
- FWCI
- 0.99
- Field percentile
- top 23%
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A network Based method to predict cancer causal genes in GR Network.
Mostafa Akhavan-Safar, Babak Teimourpour·bioRxiv·Mar 13, 2020
- Network-based estimation of therapeutic efficacy and adverse reaction potential for prioritisation of anti-cancer drug combinations
Arindam Ghosh, Vittorio Fortino·Computational and Structural Biotechnology JournalPeer-reviewed·Dec 7, 2024
- Quantifying Cancer Drug Targetability across Biochemical Pathways
Stuart Hagler·bioRxiv·Sep 27, 2024
- A Co-essentiality Network of Cancer Driver Genes Better Prioritizes Anticancer Drugs
Kwanghwan Lee, Donghyo Kim, … Sanguk Kim·Genomics Proteomics & BioinformaticsPeer-reviewed·Sep 26, 2025
- Copy number networks to guide combinatorial therapy for cancer and other disorders
Andy Lin, Desmond J. Smith·bioRxiv·Jun 24, 2014
- A Bayesian Network-Based Framework for Causal Cancer Drug Target Discovery Integrating Patient and Cell Line Data
Seok Hwan Yoon, Ye Rin Park, Hyun Uk Kim·bioRxiv·Jul 13, 2026